Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
ScPharmaceuticals is a biopharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery.
MBX Biosciences is a preclinical-stage biotech company that creates therapies to treat rare endocrine diseases.
Brenig Therapeutics develops therapies for neurodegenerative disorders.
Belenos Biosciences is a company.
Scorpion Therapeutics is a clinical-stage oncology company that specializes in precision medicine for cancer patients.
Asceneuron develops effective therapeutics for orphan tauopathies and Alzheimer’s disease.
Vanqua Bio is a biotechnology company that discovers and develops next-generation medicines for patients with neurodegenerative diseases.
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Averna Therapeutics develops genomic therapeutics that introduce therapeutic genes into safe shelters within the DNA.
Cullinan Therapeutics is a developer of an externally sourced cancer therapeutics used to end a drug program quickly.
Alterome Therapeutics is a biopharmaceutical company developing alteration-specific targeted therapies.
Nkarta Therapeutics is a developer of cell engineering platform created to build the next generation of cell therapies.
Capstan Therapeutics develops in vivo mRNA and gene-editing medicines for a broad range of diseases.
Sionna Therapeutics is developing novel small molecule therapies to treat cystic fibrosis (CF).
ImmPACT Bio USA is developing novel cell therapies for treating cancer.
Cyrus Biotechnology is a developer of Rosetta software platform that solves drug discovery problems.
ProfoundBio is a developer of targeted therapeutics intended for patients with cancer.
Noctrix Health is an early-stage medical device company that focuses on developing a revolutionary therapy for a chronic illness.
OnCusp Therapeutics is a biopharmaceutical company turning cutting-edge research assets into innovative oncology treatments.
Keros is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of novel treatments.
SpringWorks Therapeutics is a biopharmaceutical company that develops medicines for patients with severe rare diseases and cancer.
Koya Medical is a transformative healthcare company developing breakthrough treatments for lymphedema and venous diseases.
Medical documentation, Point-of-care notifications, Structured data, Open ecosystem
Alpine Immune Sciences is an immunotherapy company focused on developing treatments for autoimmune and inflammatory diseases.
OrbiMed has invested in 288 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
OrbiMed's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Pharmaceutical. The firm invests across 21 different industry categories.
Among tracked funding rounds, Cullinan Therapeutics received $280.0M in a Post-IPO Equity round. OrbiMed's total known invested capital is $31.2B.
OrbiMed's average investment size is $108.2M across its portfolio of 288 companies.
Recent OrbiMed portfolio additions include scPharmaceuticals, MBX Biosciences, Brenig Therapeutics, Belenos Biosciences, Scorpion Therapeutics. These companies were founded in 2020 or later.